Schrödinger, Inc. (NASDAQ:SDGR) Receives $32.90 Consensus Target Price from Brokerages

Shares of Schrödinger, Inc. (NASDAQ:SDGR) have been given a consensus recommendation of “Moderate Buy” by the eleven ratings firms that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $32.90.

Separately, BMO Capital Markets boosted their target price on Schrödinger from $25.00 to $28.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th.

Schrödinger Stock Up 0.7 %

Shares of SDGR opened at $19.44 on Tuesday. Schrödinger has a twelve month low of $16.67 and a twelve month high of $38.00. The stock has a market cap of $1.42 billion, a PE ratio of -8.31 and a beta of 1.56. The business’s 50-day moving average price is $19.81 and its 200-day moving average price is $20.07.

Schrödinger (NASDAQ:SDGR) last posted its earnings results on Tuesday, November 12th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by ($0.12). The firm had revenue of $35.30 million during the quarter, compared to analysts’ expectations of $41.25 million. Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The business’s revenue for the quarter was down 17.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.86) earnings per share. Analysts expect that Schrödinger will post -2.29 earnings per share for the current fiscal year.

Insider Transactions at Schrödinger

In other news, insider Margaret Dugan sold 1,531 shares of the company’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $17.78, for a total value of $27,221.18. Following the completion of the sale, the insider now owns 13,469 shares of the company’s stock, valued at approximately $239,478.82. This represents a 10.21 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 8.60% of the company’s stock.

Institutional Trading of Schrödinger

Several hedge funds have recently added to or reduced their stakes in the business. Nisa Investment Advisors LLC increased its holdings in shares of Schrödinger by 145.3% in the second quarter. Nisa Investment Advisors LLC now owns 1,413 shares of the company’s stock worth $27,000 after buying an additional 837 shares during the period. KBC Group NV boosted its holdings in Schrödinger by 45.4% during the 3rd quarter. KBC Group NV now owns 2,508 shares of the company’s stock valued at $47,000 after acquiring an additional 783 shares during the period. Quarry LP grew its position in Schrödinger by 1,150.0% during the 3rd quarter. Quarry LP now owns 2,825 shares of the company’s stock worth $52,000 after acquiring an additional 2,599 shares during the last quarter. nVerses Capital LLC purchased a new position in Schrödinger in the 2nd quarter worth approximately $66,000. Finally, Quest Partners LLC lifted its position in Schrödinger by 1,005.6% in the second quarter. Quest Partners LLC now owns 4,555 shares of the company’s stock valued at $88,000 after purchasing an additional 4,143 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.